• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 2005

View Archived Issues

Phase III ferumoxytol program recommended to continue by DMC

Read More

Cetilistat successfully completes U.S. study in obese subjects

Read More

ABT-894 begins phase I multidose trial for neuropathic pain

Read More

Triad Pharmaceuticals changes name to Arisaph Pharmaceuticals

Read More

European orphan drug designation for Bronchitol in cystic fibrosis

Read More

Phase I study for EVT-101

Read More

Phase III ACCLAIM trial of Celacade technology reaches target endpoint events

Read More

More sites for PROVIDENCE-1 study of rifalazil in intermittent claudication

Read More

Phase I study for NGX-424 for intractable pain

Read More

Promising antinociceptive effects of a novel P2X7 receptor antagonist from Abbott

Read More

CYC-116 begins IND-directed preclinical development

Read More

Fuji Pharma and JCR dissolve codevelopment agreement for JR-013

Read More

M-43068: A novel analgesic agent with reduced side effect profile

Read More

JDY-8112 protects dopaminergic neurons against inflammatory damage

Read More

AMG-0347: a novel, potent and selective TRPV1 antagonist

Read More

FDA approves new indication for Invanz

Read More

Novel histamine H3 receptor antagonists revealed by Lilly

Read More

Priority review granted for Japanese Baraclude submission

Read More

AP-23573 receives E.U. orphan drug designation for soft-tissue and bone sarcomas

Read More

Approvable letter for Thalomid sNDA for multiple myeloma

Read More

Procoralan receives European approval for chronic stable angina

Read More

New data support the use of sulodexide in the treatment of diabetic nephropathy

Read More

First data on the E1E2/MF59C.1 hepatitis C vaccine in humans

Read More

New data on the antiviral effects of Albuferon plus ribavirin in chronic hepatitis C

Read More

HepeX-B shows promise in the prevention of immune escape in HBV-infected patients

Read More

Interferon omega effective in phase II chronic hepatitis C study

Read More

Polyenylphosphatidylcholine improves peginterferon-ribavirin HCV treatment

Read More

Telbivudine superior to lamivudine in phase III hepatitis B trial

Read More

Novel agents for the treatment of neurological disorders disclosed in recent patents

Read More

Novel therapeutics for gastrointestinal disorders claimed in recent Altana patent

Read More

Novel agents for HIV infection imparted in recent patent literature

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe